1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow rhIL-15: new trials by email Literature Review of rhIL-15 trials Research Report on rhIL-15
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma rhIL-15, Avelumab - Clear-Cell Renal Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2020-05-26 | 2022-05-17 |
National Cancer Institute (NCI) (1)
United States (1)